| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus simulans |
64 |
>64 |
16 － >64 |
Ceftibuten (Cedax)  |
1492 |
| Staphylococcus simulans |
- |
- |
0.61 － ? |
Levofloxacin (Levaquin, Quixin) |
1136 |
| Staphylococcus simulans |
- |
- |
1 － ? |
Amphipathic-1D (Peptide) |
296 |
| Staphylococcus simulans |
- |
- |
1 － ? |
Amphipathic-2D (Peptide) |
296 |
| Staphylococcus simulans |
- |
- |
1 － ? |
Amphipathic-3D (Peptide) |
296 |
| Staphylococcus simulans |
- |
- |
1 － ? |
Scrambled-4D (Peptide) |
296 |
| Staphylococcus simulans |
- |
- |
1 － ? |
Segregated-5D (Peptide) |
296 |
| Staphylococcus simulans |
- |
- |
1 － ? |
Segregated-6D (Peptide) |
296 |
| Staphylococcus simulans |
- |
- |
1.22 － ? |
Levofloxacin (Levaquin, Quixin) |
1004 |
| Staphylococcus simulans |
- |
- |
610 － ? |
Ampicillin (Omnipen) |
1273 |
| Staphylococcus simulans |
- |
- |
3060 － ? |
Abies koreana (Korean Fir) (Essential oil) |
1273 |
| Staphylococcus simulans |
- |
- |
3130 － ? |
Chaenomeles speciosa (Essential oil) |
1004 |
| Staphylococcus simulans |
- |
- |
6250 － ? |
Dictamnus dasycarpus (Essential oil) |
1136 |
| Staphylococcus simulans (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
0.03 |
0.06 |
≤0.03 － 0.25 |
Retapamulin |
592 |
| Staphylococcus simulans (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
≤0.12 |
≤0.12 |
≤0.12 － >100 |
Clindamycin (Cleocin) |
592 |
| Staphylococcus simulans (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
0.12 |
0.25 |
≤0.12 － 4 |
Gentamicin (Gentamycin, Garamycin) |
592 |
| Staphylococcus simulans (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
>0.12 |
>200 |
≤0.12 － >200 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
592 |
| Staphylococcus simulans (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
≤0.25 |
≤0.25 |
≤0.25 － 0.5 |
Cephalothin (Cefalotin, Keflin, Seffin) |
592 |
| Staphylococcus simulans (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
≤0.25 |
≤0.25 |
≤0.25 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
592 |
| Staphylococcus simulans (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
0.25 |
0.5 |
≤0.12 － 8 |
Ofloxacin (Floxin) |
592 |
| Staphylococcus simulans (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
0.25 |
0.5 |
≤0.25 － 2 |
Tiamulin (Tiamuline, Tiamutilin) |
592 |
| Staphylococcus simulans (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
>0.5 |
>2 |
≤0.03 － >2 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
592 |
| Staphylococcus simulans (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
1 |
2 |
0.25 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
592 |
| Staphylococcus simulans (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
≤2 |
≤2 |
≤2 － ? |
Mupirocin (Bactroban) |
592 |
| Staphylococcus simulans (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
>4 |
>4 |
4 － >4 |
Bacitracin (Baci-IM) |
592 |
| Staphylococcus simulans (coagulase-negative + oxacillin-resistant) |
0.03 |
0.06 |
≤0.03 － 0.12 |
Retapamulin |
592 |
| Staphylococcus simulans (coagulase-negative + oxacillin-resistant) |
0.25 |
0.5 |
≤0.25 － 1 |
Tiamulin (Tiamuline, Tiamutilin) |
592 |
| Staphylococcus simulans (coagulase-negative + oxacillin-resistant) |
0.5 |
1 |
0.25 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
592 |